Vaxxinity News - VAXX

Company Name	Stock Ticker Symbol	Market	Type
Vaxxinity Inc	VAXX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.0251	-9.31%	0.2445	12:45:10

Open Price	Low Price	High Price	Close Price	Prev Close
0.2454	0.23	0.2535		0.2696

more quote information »

Recent News

Date	Time	Source	Heading
4/19/2024	18:53	GLOBE	Vaxxinity Issues Shareholder Letter
4/19/2024	16:27	GLOBE	Vaxxinity Announces Intention to Voluntarily Delist and..
3/28/2024	09:23	GLOBE	Vaxxinity to Present Clinical Data at the Annual Academy of..
3/27/2024	16:41	GLOBE	Vaxxinity Reports Fourth Quarter and Full-Year 2023..
3/07/2024	10:32	GLOBE	Vaxxinity Announces Positive Target Engagement Data from..
2/15/2024	16:15	EDGAR2	Form 8-K - Current report
2/15/2024	08:00	GLOBE	Vaxxinity’s Cholesterol Vaccine Candidate Successfully..
2/13/2024	08:00	GLOBE	Vaxxinity to Present Clinical and Preclinical Pipeline Data..
2/12/2024	17:02	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	17:02	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/30/2024	08:00	GLOBE	Vaxxinity Announces Research Collaboration on Active..
1/18/2024	08:00	GLOBE	Vaxxinity Announces Collaboration on Space Medicine Research..
1/03/2024	08:00	GLOBE	Vaxxinity to Present at the 2024 J.P. Morgan Healthcare..
12/01/2023	10:30	EDGAR2	Form 8-K - Current report
11/30/2023	17:03	EDGAR2	Form 144 - Report of proposed sale of securities
11/30/2023	16:54	EDGAR2	Form 144 - Report of proposed sale of securities
11/29/2023	17:13	EDGAR2	Form 144 - Report of proposed sale of securities
11/29/2023	17:10	EDGAR2	Form 144 - Report of proposed sale of securities
11/21/2023	16:21	EDGAR2	Form 144 - Report of proposed sale of securities
11/21/2023	16:20	EDGAR2	Form 144 - Report of proposed sale of securities
11/13/2023	18:50	GLOBE	Vaxxinity to Present at Upcoming November Medical and..
11/08/2023	08:30	GLOBE	Vaxxinity Reports Third Quarter 2023 Financial Results and..
11/08/2023	07:53	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/2023	16:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/04/2023	16:33	EDGAR2	Form 144 - Report of proposed sale of securities
10/04/2023	16:24	EDGAR2	Form 144 - Report of proposed sale of securities
9/28/2023	16:15	EDGAR2	Form 8-K - Current report
9/22/2023	16:16	EDGAR2	Form 144 - Report of proposed sale of securities
9/22/2023	16:12	EDGAR2	Form 144 - Report of proposed sale of securities
8/29/2023	08:00	GLOBE	Vaxxinity to Present at Upcoming Investor Conferences in..
8/21/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/10/2023	08:00	GLOBE	Vaxxinity Announces Publication of UB-311 Safety,..
8/09/2023	08:00	GLOBE	Vaxxinity Reports Second Quarter 2023 Financial Results and..
8/09/2023	07:31	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/09/2023	07:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/27/2023	16:30	GLOBE	Vaxxinity Appoints Peter Powchik, M.D., to Executive Vice..
7/27/2023	16:04	EDGAR2	Form 8-K - Current report
7/17/2023	08:00	GLOBE	Vaxxinity Demonstrates Target Engagement of Toxic..
6/22/2023	08:00	GLOBE	Vaxxinity Announces UB-312 Successfully Met Primary..
5/09/2023	08:00	GLOBE	Vaxxinity Reports First Quarter 2023 Financial Results and..